Topotecan might be a useful as salvage therapy for patients with refractory or relapsed primary CNS lymphoma (PCNSL)

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1556, 2006-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy of primary CNS lymphoma

By Park Deric Minwoo Abrey Lauren E

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 1, 2002-01 ,pp. : 39-49

Informa Healthcare

Access to resources Recommend Favorite

Temsirolimus: In Relapsed and/or Refractory Mantle Cell Lymphoma

By Hoy Sheridan M. McKeage Kate

Drugs, Vol. 70, Iss. 14, 2010-10 ,pp. : 1819-1829

Adis International

Access to resources Recommend Favorite

Patients with relapsed or refractory mantle cell lymphoma may receive benefit from bortezomib

Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Lenalidomide offers effective treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma

Inpharma, Vol. 1, Iss. 1648, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Preliminary Experience with Yttrium-90-labelled Rituximab (Chimeric Anti CD-20 Antibody) in Patients with Relapsed and Refractory B Cell Non-Hodgkins Lymphoma

Current Radiopharmaceuticals, Vol. 9, Iss. 2, 2016-08 ,pp. : 160-168

Bentham Science Publishers

Access to resources Recommend Favorite